We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BMY (bristol myers squibb)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
196 25 0 BMY
Emcee:  trevor john wilkinson Type:  Unmoderated
Anybody any comments

Zacks rating 2
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
196The stock was—and still is—dirt-cheap. twitter.comDewDiligence_on_SI-January 18
195BMY was under accumulation from ARK Genomics ETF: 1/14/21 - Bought 410k shares Tuan1January 18
194Anyone have any idea what sales projections are ? when does it go ex div?Dkbunts-5/4/2020
193Bmy obe of my favo stocks, look how it held up even with march market collapseDkbunts-5/4/2020
192I did not re-enter BMY (no ammunition), but... <The end of the keytruda magicMiljenko Zuanic-10/22/2019
191I exited BMY because I did not want to hold bag for CELG SH. First, let them exiMiljenko Zuanic-6/26/2019
190BMY investor sentiment has become unduly bearish, IMO. I didn’t want the CELG meDewDiligence_on_SI-6/24/2019
189<Remicade-type blockbuster> It is not revlimid type blockbuster, unless thMiljenko Zuanic-6/24/2019
188With that forced divestiture news alone, nearly all of the 8 1/2% gain I'd sThehammer-6/24/2019
187BMY can still get reasonable value for Otezla. They don't have to accept theDewDiligence_on_SI-6/24/2019
186Fuck. I bought BMY just because of Celgene's Otezla, which is shaping up tozax-6/24/2019
185Otezla for sale, Why Otezla? And who? And, for how much? 4-5X Miljenko Zuanic-6/24/2019
184The Eliquis CoM patent has already been extended, so I think the answer is no.DewDiligence_on_SI14/26/2019
183<Eliquis is a monster. Too bad it goes off-patent in 2026.> Is there any Miljenko Zuanic-4/26/2019
182You should check out Celgene's pipeline. Otezla is shaping up to be a monstzax-4/25/2019
180Eliquis is a monster. Too bad it goes off-patent in 2026.DewDiligence_on_SI-4/25/2019
179Bristol-Myers Squibb Company (BMY) 45.64 + 1.02 (+2.29%) I'm in as of 4/22 zax-4/25/2019
178Message 32005281Miljenko Zuanic-1/31/2019
177How can they believe in anything when landscape changes overnight? Even Tom sounMiljenko Zuanic-1/24/2019
176Hard to tell whether BMY executives honestly believe what they are telling invesDewDiligence_on_SI-1/24/2019
175AI approach may be proper answer when implementing bio-marker analysis before caMiljenko Zuanic-1/24/2019
1744Q CC..... some significant deterioration of the scientific rating scale at BMY;Miljenko Zuanic-1/24/2019
173From other board: Subject 24574 < Message 31960602 > MF guy is lost in hiMiljenko Zuanic-1/6/2019
172NICE continue to be key benchmark in assessing drug cost-effectiveness. Who willMiljenko Zuanic-11/30/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):